Zerviate: payments to doctors
Payments that named Zerviate as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $496K
- Providers
- 3,035
- Transactions
- 4,676
- Average per transaction
- $106
The per-transaction average — $106 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,035 providers the average total is $163, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eyevance Pharmaceuticals LLC | $495,901 | 100.0% |
| Harrow Eye, LLC | $79 | 0.0% |